Drug profiling
Our Drug Profiling services help you to
- Identify direct targets for small molecule drugs
- Elucidate the mechanism of action for drugs under development
- Become aware of alternative indications for drugs
Our Drug Profiling platform provides the link between phenotype and target
The challenge
Novel small molecule drug candidates are being increasingly identified using phenotype-based screens.
This approach delivers valuable candidates with activity in cell-based assays. However, the target of the small molecule - and consequently, the mechanism of action remain unknown.
The solution - our Drug Profiling platform
- Identifies the target(s) of a small molecule drug
- Identifies the mechanism of action
- Identifies off-target effects which may lead to side-effects later in development
Key benefits
- Speed: complete profiling of your drug in just 12 weeks
- Lowered risk: complete information on all targets of your drug, as well as potential off-target effects
- Extremely focused target lists, containing 1 — 5 targets per drug on average
- Identification of weak and transient interactions (µM range)
- Identification of low abundance targets possible
